Skip to main content
. 2022 Feb 8;11(3):884. doi: 10.3390/jcm11030884

Table 4.

Secondary safety endpoint analysis (PP population).

Periprocedural % (n/N)
Thromboembolism 3.7% (4/108)
Target aneurysm perforation 1.9% (2/108)
Vessel perforation 0.0% (0/108)
Dissection of access vessel 0.0% (0/108)
Follow-up
(Cumulative incidence) 3–6 months 7–12 months
Subarachnoid hemorrhage 1.0% (1/105) 1.1% (1/88)
Ruptured of the aneurysm 1.0% (1/105) 1.1% (1/88)
Ischemic stroke 1.0% (1/105) 2.3% (2/88)